Biocomposites to launch SYNICEM bone cement in UK to ease supply crisis
• Biocomposites responds to NHS supply crisis by bringing forward launch of its SYNICEMTM bone cement products in the UK
• Over 500,000 SYNICEMTM bone cement packs are already used by surgeons globally every year to help their patients
• The British firm is doubling global production of its SYNICEMTM bone cement products to one million packs a year to help meet NHS demand
Keele, UK, 20 February 2026 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, today announces it is making its SYNICEMTM bone cement products available in the UK with immediate effect.
